Adaptive Biotechnologies Corp Severance Agreements
4 Contracts & Agreements
- Form of Executive Severance Agreement between Adaptive Biotechnologies Corporation and certain of its executive officers (Filed With SEC on August 10, 2020)
- Executive Severance Agreement between the Registrant and Charles Sang, dated May 1, 2019 (Filed With SEC on May 30, 2019)
- Executive Severance Agreement between the Registrant and Lance Baldo, MD, dated April 22, 2019 (Filed With SEC on May 30, 2019)
- Executive Severance Agreement between the Registrant and Chad Cohen, dated May 1, 2019 (Filed With SEC on May 30, 2019)
